The proposed bill, H.B. No. 2025-2026, seeks to enact section 3902.65 of the Revised Code, which aims to prohibit certain insurance practices concerning physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions. The bill defines key terms such as "administer," "health care provider," "independent hospital," "pharmacy," "physician," and "physician-administered drug." It establishes that health benefit plans issued or renewed after January 1, 2027, cannot impose restrictions on the dispensing of physician-administered drugs based on pharmacy participation in the health plan issuer's network, nor can they require additional fees or impose increased cost-sharing based on the covered person's choice of pharmacy.

Furthermore, the bill stipulates that any limitations on coverage for physician-administered drugs must be accompanied by informed consent from the patient and a written attestation from their physician that delaying the drug's administration would not pose an increased health risk. The provisions specifically apply to patients whose conditions necessitate immediate access to these drugs, ensuring that their treatment is not hindered by insurance practices. The bill also clarifies that it does not authorize any illegal drug administration or modify existing drug administration laws in Ohio.